Prioritization of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics-Reference-Cited by-同舟云学术

Prioritization of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics

Published:2020-06-14 Issue:4 Volume:108 Page:775-790
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Arshad Usman¹^ORCID,Pertinez Henry¹,Box Helen¹,Tatham Lee¹,Rajoli Rajith K. R.¹,Curley Paul¹^ORCID,Neary Megan¹^ORCID,Sharp Joanne¹,Liptrott Neill J.¹^ORCID,Valentijn Anthony¹,David Christopher¹^ORCID,Rannard Steve P.²^ORCID,O’Neill Paul M.²,Aljayyoussi Ghaith³^ORCID,Pennington Shaun H.³^ORCID,Ward Stephen A.³^ORCID,Hill Andrew¹,Back David J.¹,Khoo Saye H.¹,Bray Patrick G.⁴,Biagini Giancarlo A.³^ORCID,Owen Andrew¹^ORCID

Affiliation:

1. Department of Molecular and Clinical Pharmacology Materials Innovation Factory University of Liverpool Liverpool UK

2. Department of Chemistry University of Liverpool Liverpool UK

3. Department of Tropical Disease Biology Liverpool School of Tropical Medicine Centre for Drugs and Diagnostics Liverpool UK

4. Pat Bray Electrical Wigan UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1909

Reference122 articles.

1. COVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral Transmission

2. World Health Organisation.COVID‐19 Trials ‐ International Clinical Trials Registry Platform (ICTRP) (2020).

3. Dysregulation of immune response in patients with COVID‐19 in Wuhan, China;Qin C.;Clin. Infect. Dis.

4. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

5. Single‐cell RNA expression profiling of ACE2, the receptor of SARS‐CoV‐2;Zhao Y.;J bioRxiv

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative pulmonary pharmacokinetics of tetrandrine for SARS-CoV-2 repurposing: a physiologically based pharmacokinetic modeling approach;Frontiers in Pharmacology;2024-09-13

2. Evaluation of potency and metabolic stability of diphyllin-derived Vacuolar-ATPase inhibitors;European Journal of Medicinal Chemistry;2024-09

3. Potential therapeutic biomolecules of hymenopteran venom against SARS-CoV-2 from Egyptian patients;Scientific Reports;2024-07-04

4. Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19;Viruses;2024-05-28

5. Effect of drug therapies on self‐reported chemosensory outcomes after COVID‐19;World Journal of Otorhinolaryngology - Head and Neck Surgery;2024-05-13